The chemical class of NDE1 inhibitors encompasses a range of compounds characterized by their interaction with NDE1 (NUDE1, NudE Neurodevelopment Protein 1), a protein integral to cell division, centrosome function, and neuronal migration. The identification and study of these compounds are driven by a deep understanding of NDE1's biological roles and the intricate pathways in which it participates. The development of these compounds is an advanced field that combines the principles of molecular biology, biochemistry, and pharmacology, focusing on the modulation of NDE1's activity within the cell. The process of discovering and characterizing compounds that can interact with NDE1 begins with an investigation into the protein's structure and its functional domains. This understanding is pivotal in pinpointing binding sites or conformational changes that can be targeted by small molecules. Advanced computational methods play a significant role in this phase, where molecular docking and virtual screening are employed to predict the interaction between NDE1 and a vast library of chemical entities. This in silico approach serves as a preliminary filter, narrowing down the candidates to those most likely to exhibit the desired interaction with NDE1. Following this, laboratory-based assays are used to validate the computational predictions. These assays typically involve measuring the binding affinity of the compounds to NDE1 or assessing their impact on NDE1's activity in vitro. Techniques like surface plasmon resonance, isothermal titration calorimetry, and various enzymatic assays are standard in these studies, providing quantitative data on the interaction between NDE1 and the compounds.
Once modulators of NDE1 are identified, the focus shifts to understanding the specific mechanism by which these compounds alter NDE1's function. This involves detailed biochemical and biophysical studies to ascertain whether the compounds act as competitive or non-competitive agents, their effect on the protein's tertiary or quaternary structure, and their impact on the protein's interaction with other cellular components. Additionally, cell-based assays are crucial to evaluate the effects of these compounds on cellular processes where NDE1 is a key player, such as in cell cycle progression, centrosome dynamics, and neuronal migration. These assays help in understanding the broader cellular implications of modulating NDE1's activity and provide insights into the selectivity and specificity of the compounds. The exploration of NDE1 modulators represents an intricate blend of multiple scientific disciplines, aimed at deepening our understanding of cellular mechanisms and protein functions. The compounds emerging from this research offer valuable tools for probing the biological roles of NDE1 and contribute significantly to the expanding field of cellular and molecular research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine affects microtubule assembly, which could possibly impact NDE1's function in cell division and neuronal migration. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin, potentially affecting NDE1's function in microtubule formation and stability. | ||||||
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
Monastrol's action on kinesin Eg5 could possibly influence NDE1's role in mitotic spindle formation and cell division. | ||||||
Purvalanol B | 212844-54-7 | sc-361300 sc-361300A | 10 mg 50 mg | $199.00 $846.00 | ||
Purvalanol A, targeting cyclin-dependent kinases, could possibly impact NDE1's function in cell cycle regulation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine, as a cyclin-dependent kinase inhibitor, could possibly affect NDE1's role in cell division and neuronal migration. | ||||||
BI6727 | 755038-65-4 | sc-364432 sc-364432A sc-364432B sc-364432C sc-364432D | 5 mg 50 mg 100 mg 500 mg 1 g | $150.00 $1050.00 $1665.00 $3329.00 $4382.00 | 1 | |
BI-2536's inhibition of Plk1 could possibly have an effect on NDE1's role in mitotic spindle assembly and centrosome function. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM447439, an Aurora kinase inhibitor, could possibly impact NDE1's function in mitosis and centrosome dynamics. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone's action as a cyclin-dependent kinase inhibitor could possibly impact NDE1's role in cell cycle progression and neuronal migration. | ||||||
Harmine | 442-51-3 | sc-202644 sc-202644A sc-202644B sc-202644C sc-202644D sc-202644E sc-202644F | 250 mg 500 mg 1 g 10 g 50 g 100 g 500 g | $53.00 $104.00 $126.00 $551.00 $1467.00 $2611.00 $11455.00 | 2 | |
Harmine's inhibition of DYRK1A, a kinase involved in neurodevelopment, could possibly affect NDE1's function in neuronal processes. | ||||||